| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.035 | 0.4 |